Incidence of Syndromes Associated With Frontotemporal Lobar Degeneration in 9 European Countries
Authors: Logroscino Giancarlo , Piccininni Marco , Graff Caroline , Hardiman Orla , Ludolph Albert C. , Moreno Fermin , Otto Markus , Remes Anne M. , Rowe James B. , Seelaar Harro , Solje Eino , Stefanova Elka , Traykov Latchezar , Jelic Vesna , Rydell Melissa Taheri , Pender Niall , Anderl-Straub Sarah , Barandiaran Myriam , Gabilondo Alazne , Krüger Johanna , Murley Alexander G. , Rittman Timothy , van der Ende Emma L. , van Swieten John C. , Hartikainen Päivi , Stojmenović Gorana Mandić , Mehrabian Shima , Benussi Luisa , Alberici Antonella , Dell’Abate Maria Teresa , Zecca Chiara , Borroni Barbara ,   FRONTIERS group, Belezhanska Diyana , Bianchetti Angelo , Binetti Giuliano , Cotelli Maria , Cotelli Maria Sofia , Dreharova Irena , Filardi Marco , Fostinelli Silvia , Ghidoni Roberta , Gnoni Valentina , Nacheva Genoveva , Novaković Ivana , Padovani Alessandro , Popivanov Ivo , Raycheva Margarita , Stockton Katherine , Stoyanova Katya , Suhonen Noora-Maria , Tainta Mikel , Toncheva Draga , Urso Daniele , Zlatareva Dora , Zulaica Miren 
Published: January 2023

Importance

Diagnostic incidence data for syndromes associated with frontotemporal lobar degeneration (FTLD) in multinational studies are urgent in light of upcoming therapeutic approaches.

Objective

To assess the incidence of FTLD across Europe.

Design, Setting, and Participants

The Frontotemporal Dementia Incidence European Research Study (FRONTIERS) was a retrospective cohort study conducted from June 1, 2018, to May 31, 2019, using a population-based registry from 13 tertiary FTLD research clinics from the UK, the Netherlands, Finland, Sweden, Spain, Bulgaria, Serbia, Germany, and Italy and including all new FTLD-associated cases during the study period, with a combined catchment population of 11 023 643 person-years. Included patients fulfilled criteria for the behavioral variant of frontotemporal dementia (BVFTD), the nonfluent variant or semantic variant of primary progressive aphasia (PPA), unspecified PPA, progressive supranuclear palsy, corticobasal syndrome, or frontotemporal dementia with amyotrophic lateral sclerosis (FTD-ALS). Data were analyzed from July 19 to December 7, 2021.

Main Outcomes and Measures

Random-intercept Poisson models were used to obtain estimates of the European FTLD incidence rate accounting for geographic heterogeneity.

Results

Based on 267 identified cases (mean [SD] patient age, 66.70 [9.02] years; 156 males [58.43%]), the estimated annual incidence rate for FTLD in Europe was 2.36 cases per 100 000 person-years (95% CI, 1.59-3.51 cases per 100 000 person-years). There was a progressive increase in FTLD incidence across age, reaching its peak at the age of 71 years, with 13.09 cases per 100 000 person-years (95% CI, 8.46-18.93 cases per 100 000 person-years) among men and 7.88 cases per 100 000 person-years (95% CI, 5.39-11.60 cases per 100 000 person-years) among women. Overall, the incidence was higher among men (2.84 cases per 100 000 person-years; 95% CI, 1.88-4.27 cases per 100 000 person-years) than among women (1.91 cases per 100 000 person-years; 95% CI, 1.26-2.91 cases per 100 000 person-years). BVFTD was the most common phenotype (107 cases [40.07%]), followed by PPA (76 [28.46%]) and extrapyramidal phenotypes (69 [25.84%]). FTD-ALS was the rarest phenotype (15 cases [5.62%]). A total of 95 patients with FTLD (35.58%) had a family history of dementia. The estimated number of new FTLD cases per year in Europe was 12 057.

Conclusions and Relevance

The findings suggest that FTLD-associated syndromes are more common than previously recognized, and diagnosis should be considered at any age. Improved knowledge of FTLD incidence may contribute to appropriate health and social care planning and in the design of future clinical trials.